Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China

NCT04954131 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

766

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Candidate Vaccine, SCB-2019
OTHER: Placebo

Sponsor

Zhejiang Clover Biopharmaceuticals, Inc.